Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Characteristics of peritoneal dialysis patients, stratified by presence of CKD-aP (yes/no) at baseline. Parameters | Total patientsN = 407 | No CKD-aPN = 196 | CKD-aPN = 211 | P-value: Calcitriol/Vitamin D analogues | 177 (43.5) | 89 (45.4) | 88(47.1) | 0.452

Source: Results table. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

PD patients were identified with different trajectories of serum phosphate by group-based trajectory modeling.

Source: Abstract.

This study was conducted in two parts (a cross-sectional analysis and a longitudinal analysis) to explore the relationship between serum phosphate and CKD-aP in a comprehensive and in-depth manner.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Does transient serum phosphate or serum phosphate status cause chronic kidney disease-associated pruritus in peritoneal dialysis patients? A cross-sectional and group-based trajectory modeling study

Cross-sectional study · Renal Failure · 2025

Original publication title

Does transient serum phosphate or serum phosphate status cause chronic kidney disease-associated pruritus in peritoneal dialysis patients? A cross-sectional and group-based trajectory modeling study

Zijun Zhou; Hanqing Zhang; Yunze Xing; Tao Zhang; Yaxuan Fang; Yueqi Zhang; Hanqi Yang; Junchen Li; Yintao Zhang; Bo Yang

© 2025 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Our study confirmed the relationship between serum phosphate and CKD-aP within the past 3 months, to some extent explaining the controversy generated by previous studies. These results may help clinicians better understand the relationship between serum phosphate and CKD-aP and the importance of controlling serum phosphate.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Chronic kidney disease-associated pruritus (CKD-aP) is a common complication in peritoneal dialysis (PD) patients. Whether serum phosphate is associated with CKD-aP is controversial. We identified the serum phosphate trajectories of PD patients in the last 3 months and investigated the effects of serum phosphate persistence on CKD-aP.

Source: Background

Abstract: What methods does the paper describe?

A total of 407 PD patients from the PD Center of the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine were included. The 14-item UP-Dial was used to investigate the prevalence and clinical characteristics. PD patients were identified with different trajectories of serum phosphate by group-based trajectory modeling.

Source: Methods

Abstract: Results

The prevalence of CKD-aP in PD patients was 51.8%. Among 407 PD patients, four distinct serum phosphate trajectories were identified. Both transient serum phosphate and serum phosphate status were associated with CKD-aP. Transient serum phosphate was associated with an increased risk of CKD-aP [OR (95%CI): 2.28 (1.30 to 4.02), 2.24 (1.22 to 4.10), 3.04 (1.66 to 5.58), 2.12 (1.21 to 3.70), respectively]. Compared with the persistent low-level group, the gradual increase group was not associated with an increased risk of CKD-aP [OR (95%CI): 1.59 (0.77 to 3.26)]. Both the gradual decrease group and the persistent high-level group were positively associated with an increased risk of CKD-aP [OR (95%CI): 2.18 (1.30 to 3.66), 3.19 (1.60 to 6.36), respectively].

Source: Results

Abstract: Conclusion

Our study confirmed the relationship between serum phosphate and CKD-aP within the past 3 months, to some extent explaining the controversy generated by previous studies. These results may help clinicians better understand the relationship between serum phosphate and CKD-aP and the importance of controlling serum phosphate.

Source: Conclusion
Authors’ abstract

Abstract

Background

Chronic kidney disease-associated pruritus (CKD-aP) is a common complication in peritoneal dialysis (PD) patients. Whether serum phosphate is associated with CKD-aP is controversial. We identified the serum phosphate trajectories of PD patients in the last 3 months and investigated the effects of serum phosphate persistence on CKD-aP.

Methods

A total of 407 PD patients from the PD Center of the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine were included. The 14-item UP-Dial was used to investigate the prevalence and clinical characteristics. PD patients were identified with different trajectories of serum phosphate by group-based trajectory modeling.

Results

The prevalence of CKD-aP in PD patients was 51.8%. Among 407 PD patients, four distinct serum phosphate trajectories were identified. Both transient serum phosphate and serum phosphate status were associated with CKD-aP. Transient serum phosphate was associated with an increased risk of CKD-aP [OR (95%CI): 2.28 (1.30 to 4.02), 2.24 (1.22 to 4.10), 3.04 (1.66 to 5.58), 2.12 (1.21 to 3.70), respectively]. Compared with the persistent low-level group, the gradual increase group was not associated with an increased risk of CKD-aP [OR (95%CI): 1.59 (0.77 to 3.26)]. Both the gradual decrease group and the persistent high-level group were positively associated with an increased risk of CKD-aP [OR (95%CI): 2.18 (1.30 to 3.66), 3.19 (1.60 to 6.36), respectively].

Conclusion

Our study confirmed the relationship between serum phosphate and CKD-aP within the past 3 months, to some extent explaining the controversy generated by previous studies. These results may help clinicians better understand the relationship between serum phosphate and CKD-aP and the importance of controlling serum phosphate.

Publication and source details

Original title: Does transient serum phosphate or serum phosphate status cause chronic kidney disease-associated pruritus in peritoneal dialysis patients? A cross-sectional and group-based trajectory modeling study

Zijun Zhou; Hanqing Zhang; Yunze Xing; Tao Zhang; Yaxuan Fang; Yueqi Zhang; Hanqi Yang; Junchen Li; Yintao Zhang; Bo Yang

Renal Failure · 2025

‡

These authors contributed equally to this work.

Supplemental data for this article can be accessed online at https://doi.org/10.1080/0886022X.2025.2540557.

CONTACT Bo Yang yb8203@126.com Department of Nephrology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Liqizhuang Street, Xiqing District, Tianjin300380, China.
© 2025 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.2025The Author(s)https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T03:36:42.794937+00:00

DOI: 10.1080/0886022x.2025.2540557 · PMC12329824